Clicky

Wednesday, October 28, 2026

Companies

Public company updates

JPMorgan Public & Private Income Fund names Glenn J. Hill CEO

JPMorgan Public & Private Income Fund announces Glenn J. Hill as its new CEO, marking a significant leadership change within the investment management sector.

Venrock Healthcare Capital Partners XP Reports Major Stake in Lycia

Venrock Healthcare Capital Partners XP, L.P. reveals significant ownership in Lycia Therapeutics, signaling a strategic investment in the biological products sector.

Matheson Lee files ownership report, holds no securities

Matheson Lee's recent filing shows no ownership of securities in Mattel, reflecting a notable transparency in executive holdings.

Duanshi Chloe Tianyu files Form 3 as Portfolio Manager

Duanshi Chloe Tianyu files Form 3, revealing her role as Portfolio Manager at Rockefeller Multi Alternatives Portfolio, emphasizing governance and transparency.

Morris Aaron Thomas Files Form 3 as Director at Empery Digital

Morris Aaron Thomas has filed a Form 3, indicating his role as a director at Empery Digital Inc., emphasizing the company's commitment to transparency.

Rockefeller Multi Alternatives Portfolio Updates Officer Ownership

Rockefeller Multi Alternatives Portfolio reports a change in officer ownership with Clark Casey Collins now listed, signaling potential strategic shifts.

Robertson Edward Taylor Files Ownership Report for Empery Digital

Robertson Edward Taylor files Form 3, indicating ownership in Empery Digital Inc., highlighting his role as a director and compliance with SEC regulations.

Klaber Jacqueline Allison Reports Ownership Change in Portfolio

Klaber Jacqueline Allison files ownership report for Rockefeller Multi Alternatives Portfolio, indicating her role as a portfolio manager.

Bruns Christopher Reports 20,000 Shares in LGL Group Inc

Christopher Bruns, VP and Controller of LGL Group Inc, discloses ownership of 20,000 shares, including unvested restricted stock.

Wise Group plc reports ownership change by director Eilam Barak

Wise Group plc files Form 3, revealing Eilam Barak's ownership change, highlighting transparency in the business services sector.

Eli Lilly Takes Major Stake in Lycia Therapeutics

Eli Lilly & Co. acquires a significant stake in Lycia Therapeutics, signaling a strategic partnership in the biological products sector.

Lycia Therapeutics reports new stock option for director

Lycia Therapeutics has filed a new ownership report indicating a stock option grant for director Jane Henderson, reflecting ongoing executive incentives.

John Carethers Files Form 3, Reports Share Ownership in AbbVie

John Carethers has filed a Form 3, indicating his ownership of shares in AbbVie Inc., highlighting compliance in the pharmaceutical industry.

Hastings Gregory S Reports Change in Neogen Corp Ownership

Hastings Gregory S reports a change in his ownership of Neogen Corp, indicating a direct ownership of 32,368 shares. This impacts corporate governance.

Lycia Therapeutics Reports Changes in Ownership Structure

Lycia Therapeutics, Inc. announces changes in ownership structure, impacting its position in the biological products sector.

Ding Shaoxiang Files Form 3, Reflecting Ownership Change

Ding Shaoxiang, a director at Amer Sports, files Form 3 indicating a change in ownership status. Key update for the apparel manufacturing sector.

Fertitta Michael D files Form 3, shows no securities ownership

Michael D. Fertitta's recent Form 3 filing reveals no ownership of Smith & Wesson securities, impacting investor perceptions in the ordnance industry.

Versant Vantage II GP Reports Ownership Changes in Lycia

Versant Vantage II GP, L.P. updates on its ownership stakes in Lycia Therapeutics, signaling strategic interests in the biotech sector.

Health In Tech, Inc. CEO Discloses Share Ownership Update

Health In Tech, Inc. CEO Sanjay Shrestha reports ownership of 101,200 shares, emphasizing transparency in the insurance industry.

Lee Chin Hyok Reports New Stock Options at Lycia Therapeutics

Lee Chin Hyok, Chief Medical Officer at Lycia Therapeutics, reports new stock options, reflecting the company's commitment to executive compensation.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →